Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents.

Zanaty, Mario; Park, Brian J; Seaman, Scott C; Cliffton, William E; Woodiwiss, Timothy; Piscopo, Anthony; Howard, Matthew A; Abode-Iyamah, Kingsley

Zanaty, Mario; Park, Brian J; Seaman, Scott C; Cliffton, William E; Woodiwiss, Timothy; Piscopo, Anthony; Howard, Matthew A; Abode-Iyamah, Kingsley.

Afiliación

Zanaty M; Department of Neurosurgery, University of Iowa, Iowa City, IA, United States.
Park BJ; Department of Neurosurgery, University of Iowa, Iowa City, IA, United States.
Seaman SC; Department of Neurosurgery, University of Iowa, Iowa City, IA, United States.
Cliffton WE; Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States.
Woodiwiss T; Department of Neurosurgery, University of Iowa, Iowa City, IA, United States.
Piscopo A; Department of Neurosurgery, University of Iowa, Iowa City, IA, United States.
Howard MA; Department of Neurosurgery, University of Iowa, Iowa City, IA, United States.
Abode-Iyamah K; Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States.

Front Neurol ; 10: 1401, 2019.

Article en En | MEDLINE | ID: mdl-32010052

Palabras clave

anticoagulation; antiplatelet; chronic subdural hematoma; machine learning; oral anticoagulation; recurrence; stroke

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google